In the treatment of aggressive lymphomas and blood cancer (leukaemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used.
Scientists develop safer CAR T-cell strategy for treating lymphomas
- Post author:
- Post published:February 9, 2024
- Post category:uncategorized